Cargando...
Cumulative Cisplatin Dose Is Not Associated With Event-Free or Overall Survival in Children With Newly Diagnosed Average-Risk Medulloblastoma Treated With Cisplatin Based Adjuvant Chemotherapy: Report From the Children's Oncology Group
BACKGROUND: Survival rates for children with medulloblastoma have risen over the past decade, in part due to the addition of cisplatin-containing adjuvant chemotherapy. Total dose of cisplatin required for optimal treatment is unknown. The purpose of this study was to evaluate the survival outcomes...
Gardado en:
| Publicado en: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591537/ https://ncbi.nlm.nih.gov/pubmed/23956184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24670 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|